Saudi Arabia Diabetes Devices Market Size: Analysis By Device Type (Blood Glucose Monitoring (BGM) Devices, Insulin Delivery Devices), By Digital Diabetes Management (Smart Glucose Meters, Smart Insulin Pens, Smart Insulin Pumps / Closed Loop Systems, Mobile Applications), By End-User (Hospitals & C

Market Outlook

The Saudi Arabia Diabetes Devices Market was valued at USD 200.72 Million in 2024 and is projected to grow to USD 325.66 Million by 2030, with a compound annual growth rate (CAGR) of 8.4% from 2025 to 2030. The Saudi Arabia Diabetes Devices Market encompasses a range of medical technologies and instruments aimed at monitoring, managing, and treating diabetes. This includes blood glucose meters, continuous glucose monitoring (CGM) systems, insulin pumps, smart insulin pens, and testing strips, all designed to enhance patient outcomes and mitigate the risks of diabetes-related complications. With the increasing prevalence of diabetes in the Kingdom, largely due to lifestyle changes, sedentary habits, and dietary choices, this market has become a crucial component of the healthcare system.

The Saudi Arabia Diabetes Devices Market is experiencing growth driven by government-led healthcare initiatives, heightened awareness regarding the importance of self-monitoring blood glucose, and technological advancements in digital health solutions. Devices that offer improved connectivity, data-sharing features, and integration with mobile applications are particularly appealing to younger, tech-oriented patients. Additionally, the strong emphasis on preventive care and the ongoing expansion of healthcare infrastructure throughout Saudi Arabia are further fueling market growth.

Moreover, collaborations between international medical device manufacturers and local distributors are enhancing product availability, ensuring that patients can access advanced insulin delivery systems and monitoring tools more readily. However, there remain challenges such as the affordability of these advanced devices and limited awareness in rural areas, which continue to pose barriers to widespread adoption.

Key Insights

In terms of Device Type, the Blood Glucose Monitoring (BGM) Devices accounted for a major share of 59% in 2024. In the Saudi Arabia Diabetes Devices Market, Blood Glucose Monitoring (BGM) devices have established themselves as the leading choice.

This trend is largely attributed to the rising number of diabetes cases in the country, which has intensified the need for regular and precise blood glucose monitoring to manage the condition effectively. Patients widely embrace BGM devices for home use, as they provide convenience and enable early detection of changes in glucose levels. A growing number of awareness campaigns, supportive government initiatives for diabetes management, and the introduction of advanced portable monitoring systems are all contributing factors to the increasing adoption of these devices. Consequently, BGM devices command a significant share of the market, surpassing that of insulin delivery devices.

Estimated prevalence of diabetes across all regions of Saudi Arabia

In the Al-Bahah region, the prevalence of diabetes reaches a concerning 18.4%, highlighting a significant public health challenge. This high rate may be associated with several factors, including genetic predispositions, dietary habits, and a lack of effective preventive healthcare programs. Conversely, regions like Jizan and Najran report much lower prevalence rates at 7.3%. This could indicate healthier populations or, alternatively, an underdiagnosis stemming from limited access to healthcare services.

In central areas such as Riyadh and the Eastern Province, diabetes prevalence falls between 10% and 10.3%. These moderate rates are likely influenced by urbanization, sedentary lifestyles, and high obesity rates, all recognized as risk factors for type 2 diabetes. Additionally, regions including Makkah, Hail, and Al-Qassim display intermediate prevalence rates, which reflect a combination of urban and rural communities with differing access to medical facilities and diabetes awareness initiatives.

Segmental Analysis

Based on Device Type, the Saudi Arabia Diabetes Devices Market is segmented into Blood Glucose Monitoring (BGM) Devices, Insulin Delivery Devices.

In Saudi Arabia, the market for diabetes devices is largely dominated by Blood Glucose Monitoring (BGM) devices. This is mainly due to the high rates of type-2 diabetes and obesity, along with the increasing need for people to regularly track their glucose levels. BGM devices, which include both self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring (CGM) systems, have become a go-to option for many patients. They allow individuals to keep an eye on their glucose levels in real time, helping them make the necessary adjustments to their diet, lifestyle, or treatment.

Given that Saudi Arabia has one of the highest diabetes rates in the world, the demand for frequent and reliable glucose testing is crucial for managing the condition. SMBG devices are particularly popular because they are more affordable and accessible, making them ideal for daily use, especially at home. On the other hand, CGMs are gaining traction thanks to growing awareness about their advantages, including continuous data tracking, a lower risk of hypoglycemia, and better control over HbA1c levels.

Government initiatives and health awareness campaigns from the Saudi Ministry of Health are encouraging people to get diagnosed early and to monitor their diabetes regularly, which helps boost the use of these devices. Additionally, increased investments in healthcare infrastructure and the rise of digital health platforms are making these devices more available and easier to use. The popularity of connected BGM systems that work with smartphones and health apps is also contributing to growth in this market, especially among younger, tech-savvy individuals.

Regional Landscape

The market for diabetes devices in Saudi Arabia is rapidly expanding, largely due to the high rates of type-2 diabetes and related health issues in the country. However, the demand for these devices isn’t evenly spread out; it’s more pronounced in urban areas.

In the Central region, with Riyadh as its hub, about 35% of the market is located here. This is where you'll find the highest number of specialized hospitals and clinics, as well as advanced diagnostic centers. The Western region, which includes Jeddah and Makkah, follows closely behind with nearly 30% market share, thanks to its large population and strong private healthcare facilities. The Eastern region, featuring cities like Dammam and Khobar, accounts for around 20%, benefiting from a wealthier population and modern healthcare options. In contrast, the Southern and Northern regions make up about 15% of the market, reflecting their smaller populations and limited access to specialized diabetes care.

Government initiatives under Vision 2030 are aiming to modernize healthcare and focus on preventive care, which is creating a more favorable environment for adopting blood glucose monitoring and insulin delivery technologies. Urban areas are seeing a quicker uptake of continuous glucose monitors and insulin pumps, while more remote regions still tend to rely on traditional blood glucose meters due to cost considerations and accessibility issues. As public awareness rises, insurance coverage expands, and digital health solutions continue to grow, we can expect some of the regional disparities in diabetes care to start leveling out.

Competitive Landscape

Some of the major companies operating within the market are: Abbott Laboratories, DexCom Inc, Roche Holding AG, Bayer AG, Novo Nordisk A/S ADR, Johnson & Johnson, B. Braun, Sanofi SA, Insulet Corp, Medtronic PLC and Others.